[b]$EAPH .0028 Point Form DD[/b] > >
[b] AMAZING DAILY Chart [/b] > > http://scharts.co/1cyQP1b
[b] HUGE INSIDERS CEO & V.P. of AXXESS PHARMACEUTICAL (AXXE $1.00 pps) EACH OWN 10,000,000 RESTRICTED SHARES, THAT IS 20,000,000.. [/b]
[b] NEW CEO NEIL MELLOR worked with MERCK,PFIZOR,ABBOTTS LABORATORIES [/b]
[color=green][b] BIG NAMES To be Announced [/b] > > Through the recent appointment of new directors, consultants and key personnel who have yet to be formally announced.[/color]
[b] NEW NAME Change any day ASHLEY BIOMEDICAL [/b]
[b] NEW WEBSITE [/b] ashleybiomedical.com (under construction)
[b]$EAPH OTCQB BOUND[/b] > >
Since a Corporate Update in April 2013, we have had a combined 15 PRs/FILINGS...and a Tier Uplist.
[color=green][b] HUGE PATENTS 15 US and 9 Foreign...plus numerous other Apps... [/b][/color]
GREAT PRODUCTS in a $10 Billion Industry & a $9 Billion Industry...
[b] FLAGSHIP PRODUCT [/b] > > The company's updated gel formulation is an innovative and thought to be unique transdermal delivery system. Easton Pharmaceuticals? flagship product, VIORRA, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on womens sexual desire and arousal, FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.
[b] 3 NEW PRODUCTS [/b] > > The company is pleased to announce a topical OTC WOUND HEALING PRODUCT, a TOPICALLY APPLIED PAIN GEL and a MOTION SICKNESS PRODUCT
[b] 4th HUGE PRODUCT [/b] > > ENTERING MARIJUANA INDUSTRY as of JUNE 2013 Billion Dollar Industry
[b] SHARE STRUCTURE is AMAZING [/b]
O/S 127 MILLION
[b] FLOAT 26 MILLION [/b]
A/S 250 MILLION
[b] RESTRICTED 101 MILLION as per LAST Q [/b]
Best thing I can say is EAPH is waking up in a Fast Way...
[b] AMAZING DAILY Chart [/b] > > http://scharts.co/1cyQP1b
[b] HUGE INSIDERS CEO & V.P. of AXXESS PHARMACEUTICAL (AXXE $1.00 pps) EACH OWN 10,000,000 RESTRICTED SHARES, THAT IS 20,000,000.. [/b]
[b] NEW CEO NEIL MELLOR worked with MERCK,PFIZOR,ABBOTTS LABORATORIES [/b]
[color=green][b] BIG NAMES To be Announced [/b] > > Through the recent appointment of new directors, consultants and key personnel who have yet to be formally announced.[/color]
[b] NEW NAME Change any day ASHLEY BIOMEDICAL [/b]
[b] NEW WEBSITE [/b] ashleybiomedical.com (under construction)
[b]$EAPH OTCQB BOUND[/b] > >
Since a Corporate Update in April 2013, we have had a combined 15 PRs/FILINGS...and a Tier Uplist.
[color=green][b] HUGE PATENTS 15 US and 9 Foreign...plus numerous other Apps... [/b][/color]
GREAT PRODUCTS in a $10 Billion Industry & a $9 Billion Industry...
[b] FLAGSHIP PRODUCT [/b] > > The company's updated gel formulation is an innovative and thought to be unique transdermal delivery system. Easton Pharmaceuticals? flagship product, VIORRA, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on womens sexual desire and arousal, FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.
[b] 3 NEW PRODUCTS [/b] > > The company is pleased to announce a topical OTC WOUND HEALING PRODUCT, a TOPICALLY APPLIED PAIN GEL and a MOTION SICKNESS PRODUCT
[b] 4th HUGE PRODUCT [/b] > > ENTERING MARIJUANA INDUSTRY as of JUNE 2013 Billion Dollar Industry
[b] SHARE STRUCTURE is AMAZING [/b]
O/S 127 MILLION
[b] FLOAT 26 MILLION [/b]
A/S 250 MILLION
[b] RESTRICTED 101 MILLION as per LAST Q [/b]
Best thing I can say is EAPH is waking up in a Fast Way...
